Effectiveness of neuraminidase inhibitors to prevent mortality in patients with laboratory-confirmed avian influenza A H7N9
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 103, 573-578
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysisInfluenza and Other Respiratory Viruses, 2016
- Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) VirusesJournal of Virology, 2015
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trialsThe Lancet, 2015
- Characterization of Drug-Resistant Influenza A(H7N9) Variants Isolated From an Oseltamivir-Treated Patient in TaiwanThe Journal of Infectious Diseases, 2014
- Clinical Findings in 111 Cases of Influenza A (H7N9) Virus InfectionNew England Journal of Medicine, 2013
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) VirusNew England Journal of Medicine, 2013
- Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trialsFamily Practice, 2012
- Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and SpreadPLOS Computational Biology, 2007
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000